Evidence map›Paper›PMID 30808942›Full record

ArticleScientific reports2019

A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta.

Alyce McClellan, Richard Evans, Cheryl Sze, Shohei Kan, Yasmin Paterson, Deborah Guest

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. In Vitro Modulation of Murine Tenocyte Behavior by Hyperbaric Oxygen Therapy.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Models of tendon development and injury.BMC biomedical engineering · 2019
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alyce McClellanCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK.
Richard EvansCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK.
Cheryl SzeCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK.
Shohei KanCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK.
Yasmin PatersonCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK.
Deborah GuestCentre for Preventive Medicine, Animal Health Trust, Newmarket, Suffolk, CB8 7UU, UK. debbie.guest@aht.org.uk.ORCID 0000-0002-0034-3332
Animal Health Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin 1β (IL-1β) is upregulated following tendon injury. Here we demonstrate that in adult and fetal tenocytes IL-1β increases the expression of matrix metalloproteinases, tenascin-C and Sox9 and decreases the expression of scleraxis and cartilage oligomeric matrix protein. When cultured in 3-dimensional collagen gels adult and fetal tenocytes exposed to IL-1β have reduced contraction ability and generate tendon-like constructs with a lower storage modulus. In contrast, equine embryonic stem cell (ESC) derived tenocytes exposed to IL-1β exhibit no changes in gene expression and generate identical tendon-like constructs. We propose that ESC-derived tenocytes do not respond to IL-1β due to their low expression of interleukin 1 (IL-1) receptor 1 and high expression of the decoy receptor IL-1 receptor 2 and IL-1 receptor antagonist protein (IL1Ra). This may make ESC-derived tenocytes an advantageous source of cells for tissue regeneration and allow the development of novel pharmaceutical interventions to protect endogenous cells from inflammation.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell Culture TechniquesCells, CulturedCollagenEmbryonic Stem CellsFetusGene ExpressionHorsesInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinMatrix MetalloproteinasesSignal TransductionTenascinTenocytesBasic Helix-Loop-Helix ProteinsCollagenInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinMatrix MetalloproteinasesTenascin

Identifiers

PMID30808942
PMCPMC6391488
OpenAlexW2916948692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.